#ADS19Boston Twitter: @AmerDelirium Facebook: @theAmericanDeliriumSociety
Welcome to Boston, Massachusetts, for the 2019 Annual Meeting of the American Delirium Society! The 3-day conference draws investigators, educators, and clinicians from all spectrums of healthcare and is truly the destination for professionals dedicated to delirium care at every level of their career. The ADS meeting is all about learning, networking, and making connections. This gathering engages a diverse group of attendees across many disciplines and countries – all dedicated to making a difference in patients across all care settings who are at risk for delirium or who develop delirium. Our 2019 Annual Meeting is larger than ever with 90 international faculty, 40 symposiums and workshops, 100 moderated posters, and 10 oral abstract sessions. We are proud to say that at ADS 2019 there will be something for everyone!
ADS Boston 2019 Conference Planning Committee:
Clay Angel MD; Andrew Auerbach MD; Leanne Boehm RN, PhD; Kristin Brooks MD, MS; Heidi Engel DPT; Timothy Girard MD, MPH; Dae Kim MD, MPH; Heidi Lindroth RN, PhD; Mark Oldham MD; Pratik Pandharipande MD, MSCI; Stephanie Rogers MD; Jane Saczynski PhD; Heidi Smith MD, MSCI.
On the eve of the 2019 Annual Meeting, the ADS Board of Directors hosted the 2019 ADS Annual Meeting Faculty Opening Reception.
Day One of the Annual Meeting began with a Mentor-Mentee and Clinical Practice Area breakfast.
Presidential Address & Recognition of Partner Organizations
John Devlin, PharmD, FCCP, FCCM
During his Presidential Address, Dr. John Devlin highlighted that over 2000 delirium related articles have been published in just the past 12 months. He proclaimed that after nearly a decade of advocacy, education, research and quality improvement, the ADS is a leader in reducing delirium around the world. At the end of the address he invited Drs Inouye, Khachurian, Rose and Barnes to feature specific initiatives.
Sharon Inouye M.D., M.P.H, representing NIDUS
Ara Khachaturian Ph.D, representing IDID: International Drive to Illuminate Delirium
Louise Rose PhD, RN, FAAN representing The Del-COrS Study
Sean Barnes M.B.A., M.D: A Primer on the Professional Role of Social Media
The Head Bone is Connected to the Body Bone: The Role of Physical Rehabilitation on Delirium in the ICU and Beyond
Plenary Presenter: Dale Needham MD, PhD
Dr. Needham championed the role of Rehabilitation and Mobility as a recommended non-pharmacological treatment for delirium. He provided evidence of the positive biological effects on cognitive functioning and the potential benefit in reducing delirium shown by recent RCTs. He asserted that the evidence is evolving with new RCTs underway, and that changes in clinical care are possible through structured QI processes. For additional ICU Rehab Solutions/Resources go to:
When Inflammation Meets Neurodegeneration: A Perfect Storm for Postoperative Delirium
Plenary Presenter: Niccolo Terrando PhD
Dr. Terrando addressed the role of inflammation in relation to neurodegeneration and how this relationship influences the development of postoperative delirium.
Exhibitor Theater: Philips Research: Towards Delirium Prevention and Detection
ADS Gold Sponsor "Philips" studies whether changes in motion are indicative for delirium in ICU patients, and pursues innovative ways of improving delirium detection and management.
Symposium: Interdisciplinary Approach to Pediatric Delirium: Evolution of Models of Care with Application of Practice-Based Evidence to Optimize Brain Health
Maalobeeka Gangopadhyay MD; Stacey Williams CPNP-AC; Lara Nelson MD; D. Catherine Fuchs MD, DFAACAP; Heidi Smith MD, MSc;
Symposium: The Role of Novel Biomarkers to Evaluate Delirium Outcomes in the Critically Ill
Sophia Wang, MD; Christopher Hughes MD; Tim Girard MD, MSc; Sikandar Khan DO, MS
Oral Abstract Session: delirium in the neurologically injured
Sophie Ryan MD; Michael Reznik MD; Tamara Fong MD, PhD; Eyal Kimchi MD, PhD; Carl Zipser MD
Roundtable: Delirium Recognition and Reduction: Practices Across the Americas
Indalecio Carboni Bisso MD; Flavia Garcez MD; Roberta Esteves Vieira de Castro MD; Patricia Mesa MD; Jose Maldonado MD
Year in Review: Critical Care/Assessment/Implementation
Michelle Weckmann MD, MS; Noll Campbell PharmD; Jin Han MD, MSc; Joanna Stollings PharmD
Network for Investigation of Delirium: Unifying Scientists (NIDUS): Overview and Updates
Sharon Inouye MD, MPH; Andrew Auerbach MD, MPH; Jan Busby-Whitehead MD; Edward Marcantonio MD, SM; Sarinnapha (Fah) Vasunilashorn PhD; Richard Jones ScD; Dale Needham MD, PhD
Michael Avidan MBBCh; Tamara Fong MD PhD; Donna Fick PhD, MSN
Real life Mentor/Mentee Pair John Devlin PharmD, FCCP, FCCM and Matthew Duprey PharmD walk down the research road to Oz with NIDUS
Workshop: A Delirium Triple Threat: 3 Phenotypes, 3 Settings, and 3 Different Rehabilitation Professionals
Tara Soudant OT; Heidi Engel DPT; Deborah Ha SLP
Board of Directors RECOGNITIONs
John Devlin PharmD, FCCP, FCCM; Marianne Shaughnessy PhD CRNP, Karin Neufeld MD, MPH, and Pratik Pandharipande MD, MSCI
ADS expresses deep gratitude for retiring board members Marianne Shaughnessy PhD CRNP, Karin Neufeld MD,MPH and Pratik Pandharipande MD, MSCI.
Babar Khan MD, MS and John Devlin PharmD, FCCP, FCCM
ADS President Elect Babar Khan MD, MS recognizes ADS Current President John Devlin PharmD, FCCP, FCCM for his service this year.
Park Plaza Ballroom Luncheon
Symposium: The ABCDEF Bundle: Implementation and Application Considerations
Leanne Boehm RN, PhD; Dale Needham MD, PhD; Federico Carini MD; Nathan Brummel MD, MSc; Kirsten Fiest MD
Symposium: Utilizing Neuro-Monitoring and Neuro-Imaging Modalities to Predict Postoperative Cognitive Outcomes
"Intraoperative Sedation Monitoring and Cognitive Outcomes": Frederick Sieber MD
"Relationship between Cerebral Autoregulation Monitoring and Postoperative Outcomes": Charlie Brown MD
"Novel Neural Signal Processing Techniques to Predict Postoperative Cognitive Outcomes": Emery Brown MD, PhD
"Diffusion MRI Pre-Operatively to Predict Postoperative Outcomes- Ready for Real Time?": Michele Cavallari MD, PhD
NIDUS Oral Abstract Session #1
Zoe Tieges; Sharon Inouye MD, MPH; Tammy Hshieh MD, MPH; Deborah D'Avollo PhD, BC-ACNP, ANP; Sarinnapha (Fah) Vasunilashorn PhD
Workshop: Innovative Geriatric Programs to Facilitate Health System Delirium Reduction Programs
Emily Simmons MSN (Not pictured: Christine Waszynski DNP, APRN; Katrina Booth MD & Shari Biswal MSN)
Symposium: What Can We Learn About Recent Antipsychotic Delirium Research?
"The MIND-USA RCT": Timothy Girard MD, MSc
"The REDUCE RCT": Mark van den Boogaard PhD, RN
"How I Use Antipsychotics in the ICU": Valerie Page MBBCh
"Utilization and Safety of Antipsychotics in Hospitalized Older Adults": Dae Kim MD, MPH
Workshop: Sustaining Organization-Wide Delirium Recognition & Intervention Programs: A Tale of Four Centers
Kristen Brooks MD, MS; Stephanie Rogers MD, MS; Benjamin Kalivas MD; Leo Pozuelo MD, FACP
NIDUS Oral Abstract Session #2
Ariba Khan MD, MPH; Eyal Kimchi MD, PhD; Towia Libermann PhD; Matthew Duprey PharmD
Symposium: Addressing the Clinical Challenges of Delirium Management in Palliative Care Settings
Shirley Bush MBBS; Peter Lawlor MB, MMedSc; Meera Agar MBBS, PhD; Anne Marie Hosie PhD, RN
Symposium: Novel Biomarkers for Predicting Postoperative Delirium Incidence and Progression of Cognitive Decline
"Novel Biomarkers to Predict Delirium and other Perioperative Neurocognitive Disorders following Anaesthesia and Surgery": Lis Evered MBiostat, MSc, PhD
"Biomarkers of Postoperative Delirium in Hip Fracture": Esther Oh MD, PhD
"Gene-Protein Interactions of Apolipoprotein E and Catecho-o-Methyltransferase Genotypes with C-Reactive Protein on Postoperative Delirium": Sarinnapha (Fah) Vasunilashorn PhD
Oral Abstract Session: Intensive Care Unit - #1
Wolfgang Ganglberger MSc; Paul Rood MSc; Karla Krewulak PhD; Carol Chan MD
Workshop: Delirium vs. Encephalopathy: Optimizing Definitions, Documentation, and Billing
Clay Angel MD; Kristen Brooks MD; Arjen Slooter MD, PhD
Poster Viewing and Reception
Sean Barnes MD discussing his poster
Park Plaza Poster Reception
Physicians / Nurses / Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco, LLC and American Delirium Society. Amedc,o LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
Amedco, LLC designates this live activity for a maximum of 20.75 AMA PRA Category 1 CreditsTM for physicians and 20.75 contact hours for nurses and 20.75 knowledge/application/practice-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity.
NOTE: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of the activity to meet the deadline for submission to CPE Monitor.